MX2007010572A - Compuestos de cinolina y su uso como moduladores de receptor x de higado. - Google Patents
Compuestos de cinolina y su uso como moduladores de receptor x de higado.Info
- Publication number
- MX2007010572A MX2007010572A MX2007010572A MX2007010572A MX2007010572A MX 2007010572 A MX2007010572 A MX 2007010572A MX 2007010572 A MX2007010572 A MX 2007010572A MX 2007010572 A MX2007010572 A MX 2007010572A MX 2007010572 A MX2007010572 A MX 2007010572A
- Authority
- MX
- Mexico
- Prior art keywords
- liver
- modilators
- receptor
- cinnoline compounds
- cinnoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Esta invencion se refiere a moduladores a base de receptores X de higado (LXRs) de la formula (I) (ver formula (I)) en donde R2 es un anillo que contiene residuos, particularmente un residuo fenilo. Estos compuestos son utiles en el tratamiento de enfermedades cardiovasculares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65729605P | 2005-03-01 | 2005-03-01 | |
PCT/US2006/007224 WO2006094034A1 (en) | 2005-03-01 | 2006-03-01 | Cinnoline compounds and their use as liver x receptor modilators |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007010572A true MX2007010572A (es) | 2007-10-04 |
Family
ID=36589080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007010572A MX2007010572A (es) | 2005-03-01 | 2006-03-01 | Compuestos de cinolina y su uso como moduladores de receptor x de higado. |
Country Status (16)
Country | Link |
---|---|
US (1) | US7700595B2 (es) |
EP (1) | EP1853566A1 (es) |
JP (1) | JP2008531709A (es) |
KR (1) | KR20070116060A (es) |
CN (1) | CN101166730A (es) |
AU (1) | AU2006218661A1 (es) |
BR (1) | BRPI0607404A2 (es) |
CA (1) | CA2599688A1 (es) |
CR (1) | CR9318A (es) |
IL (1) | IL185269A0 (es) |
MX (1) | MX2007010572A (es) |
NI (1) | NI200700223A (es) |
NO (1) | NO20074277L (es) |
RU (1) | RU2007131400A (es) |
WO (1) | WO2006094034A1 (es) |
ZA (1) | ZA200707525B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA90718C2 (ru) | 2005-05-10 | 2010-05-25 | Лаборатуар Фурнье С.А. | Новое применение агонистов печеночного рецептора х |
BRPI0716833A2 (pt) * | 2006-09-19 | 2013-11-05 | Wyeth Corp | Uso de agonistas de lxr para o tratamento de osteoartrite |
WO2008036238A2 (en) * | 2006-09-19 | 2008-03-27 | Wyeth | Use of lxr modulators for the prevention and treatment of skin aging |
CA2710454A1 (en) * | 2007-12-21 | 2009-07-09 | Wyeth Llc | Pyrazolo [1,5-a] pyrimidine compounds |
ES2941477T3 (es) | 2012-08-13 | 2023-05-23 | Univ Rockefeller | Agonista de LXRbeta para el tratamiento de cáncer |
CA3010883A1 (en) | 2016-01-11 | 2017-07-20 | The Rockefeller University | Methods for the treatment of myeloid derived suppressor cells related disorders |
EP3713575A4 (en) | 2017-11-21 | 2021-08-25 | Rgenix, Inc. | POLYMORPHS AND THEIR USES |
JP2023509845A (ja) | 2019-12-13 | 2023-03-10 | インスピルナ,インコーポレーテッド | 金属塩及びその使用 |
TWI773602B (zh) * | 2021-11-29 | 2022-08-01 | 國立陽明交通大學 | 三芳基噌啉鹽化合物及其製造方法 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE35662B1 (en) | 1970-10-16 | 1976-04-14 | Ici Ltd | Pharmaceutical compositions |
GB1474399A (en) | 1974-08-19 | 1977-05-25 | Ici Ltd | Cinnolin-3-yl carboxylic acids and derivatives thereof |
FR2528838B1 (fr) * | 1982-06-16 | 1985-10-11 | Lipha | Phenyl-5 benzodiazepines-1,3, procedes de preparation et intermediaires |
MX9200299A (es) | 1991-02-07 | 1992-12-01 | Roussel Uclaf | Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen. |
ATE156120T1 (de) * | 1991-02-07 | 1997-08-15 | Roussel Uclaf | Bizyklische stickstoffverbindungen, ihre herstellung, erhaltene zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen |
CA2102780C (en) | 1991-05-10 | 2007-01-09 | Alfred P. Spada | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
DE69333489T2 (de) | 1992-09-14 | 2005-04-14 | Takeda Chemical Industries, Ltd. | Heterocyclische Verbindungen und ihre Verwendung als Angiotensin II Antagonisten |
IL110172A (en) | 1993-07-22 | 2001-10-31 | Lilly Co Eli | Bicycle compounds and pharmaceuticals containing them |
GB9420557D0 (en) | 1994-10-12 | 1994-11-30 | Zeneca Ltd | Aromatic compounds |
US5834468A (en) | 1995-07-07 | 1998-11-10 | Zeneca Limited | Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
WO1997014681A1 (en) | 1995-10-16 | 1997-04-24 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic compounds as h+-atpases |
DE19610784A1 (de) | 1996-03-19 | 1997-09-25 | Hoechst Ag | Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
AU719392B2 (en) * | 1996-10-01 | 2000-05-11 | Kyowa Hakko Kirin Co., Ltd. | Nitrogen-containing heterocyclic compounds |
JPH10310579A (ja) | 1997-03-11 | 1998-11-24 | Sumitomo Chem Co Ltd | 4−シアノシンノリンおよびその製造法 |
DE19712960A1 (de) | 1997-03-27 | 1998-10-01 | Hoechst Ag | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
JP2002538204A (ja) | 1999-03-10 | 2002-11-12 | メルク エンド カムパニー インコーポレーテッド | 性腺刺激ホルモン放出ホルモン拮抗薬としての6−アザインドール化合物 |
EP1144416B1 (de) | 1999-11-10 | 2005-03-02 | Rodenstock GmbH | Heterocyclisch annellierte indenochromenderivate |
AU4738101A (en) | 2000-03-17 | 2001-10-03 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6559145B2 (en) | 2000-07-12 | 2003-05-06 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
US6730682B2 (en) | 2000-07-12 | 2004-05-04 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
US6562822B2 (en) | 2000-07-12 | 2003-05-13 | Pharmacia & Upjohn Company | Heterocyle carboxamides as antiviral agents |
US6887874B2 (en) * | 2000-08-09 | 2005-05-03 | Astrazeneca Ab | Cinnoline compounds |
AU1532802A (en) | 2000-10-12 | 2002-04-22 | Merck & Co Inc | Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
WO2002036734A2 (en) | 2000-10-12 | 2002-05-10 | Merck & Co., Inc. | Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
FR2816618B1 (fr) | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent |
FR2817256B1 (fr) | 2000-11-27 | 2005-07-15 | Univ Pasteur | Derives de l'acides 4-hydroxybutanoique et de son homologue superieur comme ligands des recepteurs du gamma- hydroxybutyrate (ghb), compositions pharmaceutiques les contenant et utilisations pharmaceutiques |
CA2446380A1 (en) | 2001-05-08 | 2002-11-14 | Yale University | Proteomimetic compounds and methods |
EP1270535A3 (de) | 2001-06-20 | 2004-02-18 | Clariant GmbH | Verfahren zur Herstellung von substituierten aromatischen Verbindungen |
US6632810B2 (en) | 2001-06-29 | 2003-10-14 | Kowa Co., Ltd. | Cyclic diamine compound with condensed-ring groups |
US20030187026A1 (en) * | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
CN1627944A (zh) | 2002-01-17 | 2005-06-15 | 神经能质公司 | 取代的喹唑啉-4-基胺类似物作为辣椒辣素调节剂 |
BR0307429A (pt) | 2002-02-05 | 2004-12-28 | Novo Nordisk As | Composto, uso do mesmo, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com receptor de histamina h3 |
US7074805B2 (en) | 2002-02-20 | 2006-07-11 | Abbott Laboratories | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
EP1478361A2 (en) | 2002-02-22 | 2004-11-24 | PHARMACIA & UPJOHN COMPANY | Arylsulfone derivatives |
GB0206876D0 (en) | 2002-03-22 | 2002-05-01 | Merck Sharp & Dohme | Therapeutic agents |
FR2842524B1 (fr) * | 2002-07-16 | 2005-04-22 | Aventis Pharma Sa | Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-pyrrole, leur procede de preparation a titre de medicaments |
FR2842526B1 (fr) * | 2002-07-16 | 2007-07-13 | Aventis Pharma Sa | Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments |
WO2004072042A2 (en) | 2003-02-12 | 2004-08-26 | Carex S.A. | Quinoline derivative and their use for modulation of lxr activity |
FR2856062B1 (fr) * | 2003-06-12 | 2005-11-11 | Aventis Pharma Sa | Derives 3-guanidinocarbonyl-heterocycle, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
RU2006121990A (ru) * | 2003-11-21 | 2007-12-27 | Эррэй Биофарма Инк. (Us) | Ингибиторы протеинкиназ акт |
EP1776385A1 (en) * | 2004-07-21 | 2007-04-25 | Glycofi, Inc. | Immunoglobulins comprising predominantly a glcnac2man3glcnac2 glycoform |
US20060019975A1 (en) * | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
CA2578996A1 (en) | 2004-09-03 | 2006-03-16 | Memory Pharmaceuticals Corporation | 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
US20060183763A1 (en) * | 2004-12-31 | 2006-08-17 | Pfizer Inc | Novel pyrrolidyl derivatives of heteroaromatic compounds |
-
2006
- 2006-03-01 JP JP2007558170A patent/JP2008531709A/ja active Pending
- 2006-03-01 WO PCT/US2006/007224 patent/WO2006094034A1/en active Application Filing
- 2006-03-01 BR BRPI0607404-9A patent/BRPI0607404A2/pt not_active IP Right Cessation
- 2006-03-01 AU AU2006218661A patent/AU2006218661A1/en not_active Abandoned
- 2006-03-01 CA CA002599688A patent/CA2599688A1/en not_active Abandoned
- 2006-03-01 EP EP06736530A patent/EP1853566A1/en not_active Withdrawn
- 2006-03-01 CN CNA2006800144406A patent/CN101166730A/zh active Pending
- 2006-03-01 RU RU2007131400/04A patent/RU2007131400A/ru unknown
- 2006-03-01 KR KR1020077022479A patent/KR20070116060A/ko not_active Application Discontinuation
- 2006-03-01 US US11/365,750 patent/US7700595B2/en not_active Expired - Fee Related
- 2006-03-01 MX MX2007010572A patent/MX2007010572A/es active IP Right Grant
-
2007
- 2007-08-14 IL IL185269A patent/IL185269A0/en unknown
- 2007-08-16 CR CR9318A patent/CR9318A/es not_active Application Discontinuation
- 2007-08-22 NO NO20074277A patent/NO20074277L/no not_active Application Discontinuation
- 2007-08-29 NI NI200700223A patent/NI200700223A/es unknown
- 2007-08-31 ZA ZA200707525A patent/ZA200707525B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL185269A0 (en) | 2008-02-09 |
CN101166730A (zh) | 2008-04-23 |
BRPI0607404A2 (pt) | 2009-09-01 |
NI200700223A (es) | 2008-07-03 |
US7700595B2 (en) | 2010-04-20 |
RU2007131400A (ru) | 2009-04-10 |
CR9318A (es) | 2007-10-23 |
US20060252757A1 (en) | 2006-11-09 |
JP2008531709A (ja) | 2008-08-14 |
WO2006094034A1 (en) | 2006-09-08 |
EP1853566A1 (en) | 2007-11-14 |
AU2006218661A1 (en) | 2006-09-08 |
ZA200707525B (en) | 2009-07-29 |
NO20074277L (no) | 2007-11-23 |
CA2599688A1 (en) | 2006-09-08 |
KR20070116060A (ko) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007010572A (es) | Compuestos de cinolina y su uso como moduladores de receptor x de higado. | |
GEP20084519B (en) | 3-(4-heteroarylcyclo-hexylamino) cyclopenta-necarboxamides as modulators of chemokine receptors | |
TW200716606A (en) | Chemical compounds | |
HK1113352A1 (en) | Chemical compounds | |
TW200800963A (en) | Chemical compounds | |
HK1114375A1 (en) | Chemical compounds | |
MX2009005462A (es) | Analogos de 7,8-saturados-4,5-epoxi-morfinano. | |
TW200608960A (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
TW200608966A (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
MX2009004385A (es) | Derivados de 2-[1-fenil-5-hidroxi-4alfa-metil-hexahidrociclopenta [f]indazol-5-il]etil fenilo como ligandos del receptor glucocorticoide. | |
IN2012DN00785A (es) | ||
MEP1008A (xx) | 3-aminociklopentankarboksamidi kao modulatori receptora hemokina | |
TW200745122A (en) | New compounds I | |
MEP6808A (xx) | Priperidinoilpirodolini agonisti receptora menalokortina tipa 4 | |
MX2009003227A (es) | Moduladores de los receptores de glutamato metabotropicos 5(mglur5). | |
MX2009012374A (es) | Compuestos novedosos como ligandos del receptor de canabinoides. | |
TW200738649A (en) | Calcilytic compounds | |
TW200740781A (en) | Novel compounds | |
MX2007004372A (es) | Indazoles, benzisoxazoles y benzisotiazoles y su uso como agentes estrogenicos. | |
SG158091A1 (en) | Imidazoazepinone compounds | |
MX2009012471A (es) | Compuestos 4´sustituidos que tienen afinidad al receptor 5-hidroxitriptamina 6. | |
TW200613317A (en) | Steroid prodrugs with androgenic action | |
TW200745133A (en) | New compounds II | |
DE602007007934D1 (en) | Imidazoazephinonverbindungen | |
MX2009009831A (es) | Nitrilos aromatizantes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |